US IPO Week Ahead: Rocket Companies shoots for the moon in an 8 IPO week

Updated Monday, 8/3.

Eight IPOs and one SPAC are scheduled to raise $4.8 billion in the week ahead, with Rocket Mortgage parent Rocket Companies (RKT) slated to complete the year’s largest US IPO to date.

Several companies could join the IPO calendar in the week ahead, including net lease REIT NetSTREIT (NTST), oncology biotech Inhibrx (INBX), and insurance software provider Duck Creek Technologies (DCT).

Rocket Companies (RKT) plans to raise $3.2 billion at a $42 billion market cap, with proceeds going to the parent, an affiliate of founder Dan Gilbert. Its flagship business, Rocket Mortgage, is the leading online platform for applying for a mortgage, contributing to the company’s $5.9 billion in annual revenue with $1.3 billion in earnings. Rocket has demonstrated growth and profitability, and its share of US mortgage originations grew to 9% in the 1Q20, though that is expected to fall in the 2Q.

Rackspace Technology (RXT), a leading provider of cloud management services, plans to raise $754 million at a $4.8 billion market cap. Taken private by Apollo Global in 2016, the company served over 120,000 customers across 120 countries in 2018 and 2019, including more than half of the Fortune 100. Rackspace is profitable on an EBIT basis, but quarterly revenue growth has been lumpy, and margins have fluctuated.

Health center chain Oak Street Health (OSH) plans to raise $250 million at a $3.8 billion market cap. Fast-growing and unprofitable, the company has demonstrated the ability to scale its business model with positive contribution margins and 90% patient satisfaction. It operates 54 sites in the greater Midwest and plans to open 25 new sites a year, though expansion in new markets like Dallas and New York City (where One Medical (ONEM) operates) may be challenging.

E-commerce platform BigCommerce (BIGC) plans to raise $130 million at a $1.4 billion market cap. The company serves approximately 60,000 online stores in 120 countries, while increasing its share of enterprise customers. BigCommerce is coming to market at a discount to close peer Shopify (SHOP; +5,924% from 2015 IPO), which has higher revenue, growth, and profitability.

Medical device maker Acutus Medical (AFIB) plans to raise $125 million at a $457 million market cap. The company's AcQMap imaging and mapping system offers a new approach to mapping the drivers and maintainers of cardiac arrhythmias and was made available in the US in May 2018. In the 1Q20, there were 31 customer sites with AcQMap consoles and workstations, expected to increase to 38 in the 2Q.

Gene therapy biotech Freeline Therapeutics (FRLN) plans to raise $125 million at a $574 million market cap. The company's lead candidate, FLT180a, an investigational gene therapy medicinal product candidate for the treatment of hemophilia B, is currently in a Phase 1/2 trial and has dosed 10 patients as of June 15, 2020. 

In its second IPO attempt, customer support services provider IBEX (IBEX) plans to raise $100 million at a $397 million market cap. The company’s customers include large telecoms, and it is expanding its client base into the “new economy” with customers like Amazon and Lyft. However, its revenue is still highly concentrated, and largest customer Frontier Communications recently filed for Chapter 11.

Solid tumor biotech Checkmate Pharmaceuticals (CMPI) plans to raise $75 million at a $348 million market cap. The company's sole candidate, CMP-001, has been studied in more than 200 melanoma patients to date. In its Phase 1b trial for advanced anti-PD-1 refractory melanoma, in combination with pembrolizumab and as a monotherapy, the company has observed a best objective response rate of 28%.

Media and entertainment SPAC Vistas Media Acquisition (VMACU) plans to raise $100 million. The company’s CEO previously led I-AM Capital Acquisition, which acquired Simplicity Esports and Gaming in November 2018 and now trades on the OTC under the symbol WINR.

U.S. IPO Calendar
Deal Size
Market Cap
Price Range
Shares Filed
BigCommerce (BIGC)
Austin, TX
$18 - $20
Morgan Stanley
Provides a cloud-based platform for businesses to create online stores.
Rackspace (RXT)
San Antonio, TX
$21 - $24
Leading provider of cloud management services.
Acutus Medical (AFIB)
Carlsbad, CA
$16 - $18
JP Morgan
Manufactures devices for electrophysiological mapping to treat arrhythmias.
Oak Street Health (OSH)
Chicago, IL
$15 - $17
JP Morgan
Operates primary care health facilities for Medicare patients in the Midwest.
Rocket Companies (RKT)
Detroit, MI
$20 - $22
Morgan Stanley
Leading mortgage lender operating under the Rocket and Quicken brands.
Checkmate Pharmaceuticals (CMPI)
Cambridge, MA
$14 - $16
Clinical stage immuno-oncology biotech developing therapies for solid tumors.
Freeline Therapeutics (FRLN)
Stevenage, United Kingdom
$16 - $18
JP Morgan
Morgan Stanley
Phase 1/2 biotech developing gene therapies for rare diseases.
Hamilton, Bermuda
$20 - $22
Provides outsourced customer support and marketing services.
Vistas Media Acquisition (VMACU)
New York, NY
Blank check company targeting the media and entertainment industry.

Sign up for a free trial of our premium platform, IPO Pro. Follow us on Twitter (@IPOtweet) and register for our updates on the IPO market.

Street research is expected for five companies, and lock-up periods will be expiring for seven companies. Sign up for a free trial of IPO Pro for access to Street research and lock-up expiration dates.

IPO Market Snapshot
The Renaissance IPO Indices are market cap weighted baskets of newly public companies. As of 7/30/20, the Renaissance IPO Index was up 39.9% year-to-date, while the S&P 500 was up 0.5%. Renaissance Capital's IPO ETF (NYSE: IPO) tracks the index, and top ETF holdings include Zoom Video (ZM) and Uber (UBER). The Renaissance International IPO Index was up 25.5% year-to-date, while the ACWX was down 5.8%. Renaissance Capital’s International IPO ETF (NYSE: IPOS) tracks the index, and top ETF holdings include Meituan-Dianping and Xiaomi.
The article US IPO Week Ahead: Rocket Companies shoots for the moon in an 8 IPO week originally appeared on IPO investment manager Renaissance Capital's web site

Investment Disclosure: The information and opinions expressed herein were prepared by Renaissance Capital's research analysts and do not constitute an offer to buy or sell any security. Renaissance Capital's Renaissance IPO ETF (symbol: IPO), Renaissance International ETF (symbol: IPOS), or separately managed institutional accounts may have investments in securities of companies mentioned.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


More Related Articles

Info icon

This data feed is not available at this time.

Sign up for Smart Investing to get the latest news, strategies and tips to help you invest smarter.